Pharmaceutical Organizations

Understand and Advance Real-World Safety and Value

Your product is on the market. Now it’s time to understand its effectiveness and safety in the real world. You need trusted real-world evidence to support post-market surveillance, drive research, enhance clinical trials, and guide regulatory and payment strategy. Our analytics and registry solutions deliver the precise insights you need to succeed.

Propel Your Path to Value

Demonstrate effectiveness in large, diverse patient groups.
Identify risks, complications, and adverse outcomes as they arise.
Compare new products with existing options and the standard of care.
Update guidelines as certain populations or groups find more or new benefits.
Comply with regulatory requirements.

Generate Real-World Evidence

Transform data into clinically-rich, research-grade evidence that shows how your treatment or therapy performs in real-world settings and what’s driving outcomes.

  • Acquire, aggregate, and validate large amounts of data from multiple sources with ease.
  • Turn data into trusted evidence with proven methods and models.
  • Examine treatment trends and outcomes via intuitive real-time reports and tools.

Gain Flexibility and Control of Your RWE

Our analytics technology delivers the evidence you need when and how you need it, and helps you accelerate your path to value.

  • Explore existing data and evidence.
  • Understand utilization, complications, and outcomes. 
  • Identify areas for further research and improvement.

Demonstrate Safety and Drive Value

We deliver exponential insights you can rely on to address your top priorities, deliver value, improve outcomes, and achieve results.

  • Advance research and post-market surveillance across the product lifecycle.
  • Support regulatory and payment strategy.
  • Supplement clinical trial data.
healthcare leaders trust arbormetrix
No items found.

Registries Set the Foundation for Post-Market Surveillance

Examining Treatment and Outcomes of a Common Complication

Acacia Pharma, a hospital pharmaceutical company, is leveraging a clinical registry to support a large observational study of post-operative nausea and vomiting (PONV). PONV has been cited as the most undesirable of all surgical complications, even worse than pain, in some patient surveys. It is a common complication of surgery and anesthesia that occurs in approximately 30% of surgical patients and up to 80% of high-risk patients.

The PROMPT (PONV Rescue Outcomes after aMisulPride Treatment) Study collects RWE on the presentation, evaluation, and rescue treatment of PONV. The registry-based study enables hospitals, surgeons, and anesthesia providers to better understand the drivers of perioperative complications and the impact of the management of those complications on patient throughput and workflow.

Sites that participate in the PROMPT Study use the PACE Registry to gain insight into deidentified, retrospective data collection from tens of thousands of patient records, leverage research-grade evidence suitable for publication, and access web-based reports on quality metrics, workflow, and throughput.

Ready to Make Real-World Evidence Work for You?

Clinical Data Registry use cases

One Central Source of Truth.
Endless Purpose.

Clinical Data Registry Resources

Insights to Support Your Improvement Journey

Ready to make real-world evidence work for you?

Get in touch with our team of data science and registry experts today. We'll work with you to understand:

  • Your organization's goals and priorities
  • The best path forward for your RWE program
  • How we can help you achieve results that matter